Niagen Bioscience, Inc. (FRA:OCD1)
Germany · Delayed Price · Currency is EUR 5.70
+0.10 (1.79%)
At close: Nov 28, 2025
Niagen Bioscience Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 124.71 | 99.6 | 83.57 | 72.05 | 67.45 | 59.26 | Upgrade | |
Revenue Growth (YoY) | 36.04% | 19.18% | 15.99% | 6.82% | 13.83% | 28.01% | Upgrade |
Cost of Revenue | 45.03 | 38.01 | 32.79 | 29.25 | 25.96 | 23.98 | Upgrade |
Gross Profit | 79.68 | 61.59 | 50.78 | 42.8 | 41.49 | 35.27 | Upgrade |
Selling, General & Admin | 54.44 | 47.84 | 51.42 | 56.6 | 64.73 | 51.71 | Upgrade |
Research & Development | 5.94 | 6.02 | 4.96 | 4.83 | 3.83 | 3.42 | Upgrade |
Operating Expenses | 60.38 | 53.86 | 56.38 | 61.43 | 68.56 | 55.13 | Upgrade |
Operating Income | 19.3 | 7.73 | -5.6 | -18.63 | -27.07 | -19.85 | Upgrade |
Interest Expense | - | - | - | - | -0.06 | -0.07 | Upgrade |
Interest & Investment Income | 1.95 | 1.13 | 0.66 | 0 | - | - | Upgrade |
EBT Excluding Unusual Items | 21.25 | 8.86 | -4.94 | -18.63 | -27.13 | -19.93 | Upgrade |
Other Unusual Items | - | - | - | 2.09 | - | - | Upgrade |
Pretax Income | 21.25 | 8.86 | -4.94 | -16.54 | -27.13 | -19.93 | Upgrade |
Income Tax Expense | 0.82 | 0.31 | - | - | - | - | Upgrade |
Earnings From Continuing Operations | 20.43 | 8.55 | -4.94 | -16.54 | -27.13 | -19.93 | Upgrade |
Net Income | 20.43 | 8.55 | -4.94 | -16.54 | -27.13 | -19.93 | Upgrade |
Net Income to Common | 20.43 | 8.55 | -4.94 | -16.54 | -27.13 | -19.93 | Upgrade |
Shares Outstanding (Basic) | 78 | 76 | 75 | 70 | 67 | 61 | Upgrade |
Shares Outstanding (Diluted) | 85 | 78 | 75 | 70 | 67 | 61 | Upgrade |
Shares Change (YoY) | 10.80% | 4.19% | 7.54% | 3.79% | 10.02% | 7.03% | Upgrade |
EPS (Basic) | 0.26 | 0.11 | -0.07 | -0.24 | -0.40 | -0.33 | Upgrade |
EPS (Diluted) | 0.23 | 0.11 | -0.07 | -0.24 | -0.40 | -0.33 | Upgrade |
Free Cash Flow | 21.15 | 11.95 | 6.97 | -15.43 | -24.57 | -10.72 | Upgrade |
Free Cash Flow Per Share | 0.25 | 0.15 | 0.09 | -0.22 | -0.37 | -0.18 | Upgrade |
Gross Margin | 63.89% | 61.83% | 60.76% | 59.40% | 61.51% | 59.53% | Upgrade |
Operating Margin | 15.48% | 7.76% | -6.70% | -25.85% | -40.14% | -33.51% | Upgrade |
Profit Margin | 16.38% | 8.58% | -5.91% | -22.96% | -40.22% | -33.63% | Upgrade |
Free Cash Flow Margin | 16.96% | 11.99% | 8.34% | -21.42% | -36.43% | -18.10% | Upgrade |
EBITDA | 20.08 | 8.54 | -4.57 | -17.57 | -25.96 | -18.74 | Upgrade |
EBITDA Margin | 16.10% | 8.58% | -5.47% | -24.39% | -38.48% | -31.62% | Upgrade |
D&A For EBITDA | 0.78 | 0.81 | 1.03 | 1.06 | 1.12 | 1.11 | Upgrade |
EBIT | 19.3 | 7.73 | -5.6 | -18.63 | -27.07 | -19.85 | Upgrade |
EBIT Margin | 15.48% | 7.76% | -6.70% | -25.85% | -40.14% | -33.51% | Upgrade |
Effective Tax Rate | 3.87% | 3.44% | - | - | - | - | Upgrade |
Advertising Expenses | - | 11.1 | 10.3 | 11.4 | 12.5 | 7.4 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.